Approval · Notice of Compliance 5465 · 1994
AREDIA: Notice of Compliance 5465
Issued November 24, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5465
- Date
- November 24, 1994
- Company
- Geigy Pharmaceuticals, Ciba-Geigy Canada Ltd.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AREDIA | Not yet assigned | — |
Medicinal ingredients
- PAMIDRONATE DISODIUM 30 MG per VIAL
- PAMIDRONATE DISODIUM 60 MG per VIAL
- PAMIDRONATE DISODIUM 90 MG per VIAL